This review explores the link between toxic metal exposure and cardiovascular complications in diabetes, assessing the potential benefits of edetate disodium chelation therapy. The Trial to Assess Chelation Therapy (TACT) showed that diabetic patients with a history of myocardial infarction who received chelation therapy experienced a 41% reduction in recurrent
